Cell Rising Capital
Overview
Cell Rising Capital is a Hong Kong-based venture capital firm specializing in angel to series A funding for startups across Europe and Asia. They are dedicated to forging cross-continental connections, enabling the exchange of innovative technologies between Europe and Asia. Their strategic focus encompasses diverse sectors, such as advanced manufacturing, AI, biotech, EV, fintech, medtech, and sustainability. Cell Rising Capital is a venture capital investment on cutting-edge technologies and artifical intelligence.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hex Trust | Mar 2022 | Series B | Co-investor |
| Wrisk | May 2021 | Crowdfunding | Co-investor |
| Springdel | Jun 2022 | Seed | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cell Rising Capital based?
Cell Rising Capital is headquartered in Hong Kong.
When was Cell Rising Capital founded?
Cell Rising Capital was founded in 2020.
How many portfolio companies does Cell Rising Capital have?
Cell Rising Capital has 5 portfolio companies in Caplight's dataset.
What are some companies in Cell Rising Capital's portfolio?
Portfolio companies visible on Caplight include Hex Trust, Wrisk, Springdel.
What was Cell Rising Capital's most recent investment shown here?
Cell Rising Capital's most recent investment in this portfolio sample was in Springdel in 2022.
What sectors does Cell Rising Capital focus on?
Cell Rising Capital focuses on AI, Data & Cloud Infrastructure, FinTech, Crypto & Web3, Enterprise Software, FinTech, Crypto & Web3, Frontier & Industrial Tech, Enterprise Software, FinTech, Enterprise Software.
What company stages does Cell Rising Capital focus on?
Cell Rising Capital typically invests at the Early stage.
What is Cell Rising Capital's AUM?
Cell Rising Capital's assets under management are estimated between $0.0 and $50.0M.